- Home
- INSM vs ZM Comparison
INSM vs ZM Comparison
Compare INSM & ZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSM | ZM |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2B | 25.4B |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | INSM | ZM |
|---|---|---|
| Price | $150.41 | $89.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 23 |
| Target Price | ★ $192.27 | $93.05 |
| AVG Volume (30 Days) | 2.3M | ★ 4.3M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.29 |
| EPS | N/A | ★ 5.13 |
| Revenue | $447,022,000.00 | ★ $4,805,915,000.00 |
| Revenue This Year | $57.54 | $7.21 |
| Revenue Next Year | $141.54 | $3.56 |
| P/E Ratio | ★ N/A | $18.05 |
| Revenue Growth | ★ 30.34 | 3.85 |
| 52 Week Low | $60.40 | $64.41 |
| 52 Week High | $212.75 | $97.58 |
Technical Indicators
Market Signals| Indicator | INSM | ZM |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 48.77 |
| Support Level | $142.99 | $88.60 |
| Resistance Level | $152.19 | $96.52 |
| Average True Range (ATR) | 5.58 | 4.30 |
| MACD | 0.39 | -0.21 |
| Stochastic Oscillator | 34.78 | 21.16 |
Price Performance
Historical ComparisonAbout INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About ZM Zoom Video Communications Inc.
Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.